US 11,724,111 B2
Methods and implantable medical systems that implement exposure modes of therapy that allow for continued operation during exposure to a magnetic disturbance
Hyun J. Yoon, Vadnais Heights, MN (US); Wade M. Demmer, Coon Rapids, MN (US); Matthew J. Hoffman, St. Paul, MN (US); Robert A. Betzold, Fridley, MN (US); Jonathan D. Edmonson, Blaine, MN (US); Michael L. Ellingson, St. Louis Park, MN (US); Ben W. Herberg, Andover, MN (US); Juliana E. Pronovici, New Hope, MN (US); James D. Reinke, Maple Grove, MN (US); Todd J. Sheldon, North Oaks, MN (US); and Paul R. Solheim, Blaine, MN (US)
Assigned to Medtronic, Inc., Minneapolis, MN (US)
Filed by MEDTRONIC, INC., Minneapolis, MN (US)
Filed on Apr. 19, 2021, as Appl. No. 17/234,746.
Application 16/409,921 is a division of application No. 15/487,713, filed on Apr. 14, 2017, granted, now 10,293,167, issued on May 21, 2019.
Application 17/234,746 is a continuation of application No. 16/409,921, filed on May 13, 2019, granted, now 10,981,010.
Claims priority of provisional application 62/323,560, filed on Apr. 15, 2016.
Prior Publication US 2021/0236828 A1, Aug. 5, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/37 (2006.01); A61N 1/39 (2006.01); A61N 1/368 (2006.01)
CPC A61N 1/3718 (2013.01) [A61N 1/3931 (2013.01); A61N 1/3684 (2013.01); A61N 1/3688 (2013.01); A61N 1/3956 (2013.01)] 32 Claims
OG exemplary drawing
 
1. A method of controlling an exposure mode of therapy of a first device using a second device, comprising:
determining at the second device a device type for the first device;
determining at the second device the exposure mode of therapy based on the device type and a pre-exposure mode of therapy being provided by the first device; and
providing an instruction about the exposure mode of therapy from the second device to the first device.